Search Results 1071-1080 of 16845 for monoclonal antibody

1. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

   ... antibody therapy within 42 days of registration; patients may have ... Monoclonal antibodies must not have been received for 1 week prior to registration; ...

2. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

   composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation

3. Translational Science - 2020 Archives - Mayo Clinic News Network

   Science Saturday: COVID-19 experimental antibody treatment reaches patients ... Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science ...

4. Haemophilus b conjugate vaccine (intramuscular route) - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Haemophilus b conjugate vaccine is prepared by adding ...

5. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

6. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   For prior biological therapies, eg, monoclonal antibodies with a half-life longer than 3 days, the interval must be at least 28 days prior to the first dose of ...

7. Publications - Paschalis Vergidis, M.D. - Mayo Clinic

   Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

8. A Study of the Effectiveness and Safety of Pembrolizumab (MK-3475) for Women with Advanced Recurrent Ovarian Cancer - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...

9. A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) - Mayo Clinic

   Positive for human immunodeficiency virus (HIV) or hepatitis C antibody. Positive for hepatitis B surface antigen. Splenectomy within 3 months of screening ...

10. Study of TBio-6517, Given Intratumorally, Alone or in Combination With Pembrolizumab, in Solid Tumors - Mayo Clinic

    ... monoclonal antibody (mAb) therapy within 45 days prior to study Day 1. Note: Patients are allowed to receive any of the following treatments up to 7 days ...